Sofwave Receives FDA Clearance for Treating Upper Arm Skin Laxity
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
Research suggests patients using medical weight loss drugs are increasingly seeking treatments for facial volume loss and other appearance changes.